Cardiac surgery in patients with haemophilia B: A case report and review of the literature

Haemophilia

Volumn 15, Issue 1, 2009, Pages 108-113

  Krakow, E F ^a   Walker, I ^a   Lamy, A ^a   Anderson, J A M ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

Cardiac surgery; Continuous infusion; Haemophilia B

Indexed keywords

ACETYLSALICYLIC ACID; BLOOD CLOTTING FACTOR 9; HEPARIN; PROTAMINE; RECOMBINANT BLOOD CLOTTING FACTOR 9; TRANEXAMIC ACID;

ADULT; ANGIOCARDIOGRAPHY; AORTA STENOSIS; AORTA VALVE REPLACEMENT; BICUSPID AORTIC VALVE; BLEEDING; BOLUS INJECTION; CARDIOPULMONARY BYPASS; CASE REPORT; CONTINUOUS INFUSION; DISEASE SEVERITY; ELECTIVE SURGERY; FOLLOW UP; HEART CATHETERIZATION; HEART SURGERY; HEMOPHILIA B; HEMOSTASIS; HUMAN; INTERDISCIPLINARY COMMUNICATION; LOW DRUG DOSE; MALE; OPERATION DURATION; PATIENT CARE; PREOPERATIVE CARE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVIEW; THROMBOEMBOLISM; THROMBOSIS PREVENTION; TREATMENT RESPONSE;

AORTIC VALVE; AORTIC VALVE STENOSIS; FACTOR IX; HEART VALVE PROSTHESIS IMPLANTATION; HEMOPHILIA B; HEMOSTASIS, SURGICAL; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; PERIOPERATIVE CARE; RECOMBINANT PROTEINS;

EID: 63049132558     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2008.01918.x     Document Type: Review

References (35)

1. Schulman S. Continuous infusion. Haemophilia 2003; 9: 368-75.
2. Schulman S, Wallensten R, White B, Smith OP. Efficacy of a high purity, chemically treated and nanofiltered factor IX concentrate for continuous infusion in haemophilia patients undergoing surgery. Haemophilia 1999; 5: 96-100.
3. Rosendaal FR, Briet E, Stibbe J et al. Haemophilia protects against ischaemic heart disease: A study of risk factors. Br J Haematol 1990; 75: 525-30.
4. Sramek A, Kriek M, Rosendaal FR. Decreased mortality of ischaemic heart disease among carriers of haemophilia. Lancet 2003; 362: 351-4.
5. Darby SC, Kan SW, Spooner RJ et al. Mortality rates, life expectancy, and causes of death in people with hemophilia A or B in the United Kingdom who were not infected with HIV. Blood 2007; 110: 815-25.
6. Kulkarni R, Soucie JM, Evatt BL. Hemophilia Surveillance System Project Investigators. Prevalence and risk factors for heart disease among males with hemophilia. Am J Hematol 2005; 79: 36-42.
7. Girolami A, Ruzzon E, Fabris F, Varvarikis C, Sartori R, Girolami B. Myocardial infarction and other arterial occlusions in hemophilia A patients. A cardiological evaluation of all 42 cases reported in the literature. Acta Haematol 2006; 116: 120-5.
8. Brockman SK, Aprill SN, Rabiner FS. Aortic valve replacement in hemophilia. Report of a case. JAMA 1972; 222: 660-1.
9. Lusher JM, Ravindranath Y, Arciniegas E, Green E. Open heart surgery in a hemophiliac patient. Hematologic management. Am J Dis Child 1974; 127: 708-11.
10. Nahas C, Jones JW, Beall AC Jr, Lafuente J, Irani M. Myocardial revascularization in a hemophiliac. Cardiovasc Surg 1996; 4: 557-8.
11. MacKinlay N, Taper J, Renisson F, Rickard K. Cardiac surgery and catheterization in patients with haemophilia. Haemophilia 2000; 6: 84-8.
12. Stine KC, Becton DL. Use of factor VIII replacement during open heart surgery in a patient with haemophilia A. Haemophilia 2006; 12: 435-6.
13. Murugan SJ, Viswanathan S, Thomson J, Parsons JM, Richards M. Heart surgery in infants with hemophilia. Ann Thorac Surg 2006; 81: 336-9.
14. Eren A, Friedl R, Hannekum A, Gulbins H. Cardiac surgery in a patient with haemophilia A. Thorac Cardiovasc Surg 2006; 54: 212-4.
15. Tourbaf KD, Bettigole RE, Zizzi JA, Subramanian S, Andersen MN. Coronary bypass in a patient with hemophilia B, or Christmas disease. Case report. J Thorac Cardiovasc Surg 1979; 77: 562-9.
16. Roskos RR, Gilchrist GS, Kazmier FJ, Feldt RH, Danielson GK. Management of hemophilia A and B during surgical correction of transposition of the great arteries. Mayo Clin Proc 1983; 58: 182-6.
17. Raish RJ, Witte DL, Goldsmith JC. Successful cardiac surgery following plasmapheresis in a patient with hemophilia B. Transfusion 1985; 25: 128-30.
18. Mazzucco A, Stellin G, Cantele P, Boschello M, Traldi A, Gallucci V. Repair of ventricular septal defect and aortic regurgitation associated with severe hemophilia B. Ann Thorac Surg 1986; 42: 97-9.
19. Vander Woude JC, Milam JD, Walker WE, Houchin DP, Weiland AP, Cooley DA. Cardiovascular surgery in patients with congenital plasma coagulopathies. Ann Thorac Surg 1988; 46: 283-8.
20. Wilson CJ, Frankville D, Robinson B, Koch F, Lake CL. Perioperative management of coronary artery bypass surgery in a patient with factor IX deficiency. J Cardiothorac Vasc Anesth 1991; 5: 160-2.
21. Scharfman WB, Rauch AE, Ferraris V, Burkart PT. Treatment of a patient with factor IX deficiency (hemophilia B) with coronary bypass surgery. J Thorac Cardiovasc Surg 1993; 105: 765-6.
22. Dimitrova A, Tsarianski G, Aleksandrov V, Kereshka P, Nachev G, Chirkov A. Hemophilia B and aortocoronary bypass. Khirurgiia (Sofiia) 1995; 48: 76-9.
23. Palanzo DA, Sadr FS. Coronary artery bypass grafting in a patient with haemophilia B. Perfusion 1995; 10: 265-70.
24. Bukowski JG, De Brux JL, Ganascia B, Cottineau C, Jacob JP. Coronary artery bypass with extracorporeal circulation in a patient with hemophilia B. Ann Fr Anesth Reanim 1996; 15: 304-6.
25. Helft G, Metzger JP, Samama MM, Rothschild C, Batisse JP, Vacheron A. Coronary stenting in a hemophilic patient. Thromb Haemost 1997; 77: 1044-5.
26. Donahue BS, Emerson CW, Slaughter TF. Case 1-1999. Elective and emergency cardiac surgery on a patient with hemophilia B. J Cardiothorac Vasc Anesth 1999; 13: 92-7.
27. Au WY, Jim MH, Lam CC. Unusual case of coronary artery disease in a patient with severe hemophilia B. Am J Hematol 2002; 69: 152-3.
28. Bovenzi F, De Luca L, Signore N, Fusco F, de Luca I. Abciximab for the treatment of an acute thrombotic coronary occlusion during stent implantation in a patient with severe hemophilia B. Ital Heart J 2003; 4: 728-30.
29. Grandmougin D, Delolme MC, Reynaud J, Barral X. Off-pump myocardial revascularization in a diabetic patient with severe hemophilia B and impaired left ventricular function: Hematological and operative strategies. J Card Surg 2005; 20: 366-9.
30. Thankachen R, George B, Shukla V, Korula RJ. Aortic and mitral valve replacement in a patient with hemophilia B. Asian Cardiovasc Thorac Ann 2007; 15: 526-7.
31. Tagariello G, Davoli PG, Gajo GB et al. Safety and efficacy of high-purity concentrates in haemophiliac patients undergoing surgery by continuous infusion. Haemophilia 1999; 5: 426-30.
32. Chowdary P, Dasani H, Jones JA et al. Recombinant factor IX (B ene F ix ®) by adjusted continuous infusion: A study of stability, sterility and clinical experience. Haemophilia 2001; 7: 140-5.
33. Ragni MV, Pasi KJ, White GC, Giangrande PL, Courter SG, Tubridy KL. Use of recombinant factor IX in subjects with haemophilia B undergoing surgery. Haemophilia 2002; 8: 91-7.
34. Hoots WK, Leissinger C, Stabler S et al. Continuous intravenous infusion of a plasma-derived factor IX concentrate (Mononine) in haemophilia B. Haemophilia 2003; 9: 164-72.
35. van Hylckama Vlieg A, van der Linden IK, Bertina RM, Rosendaal FR. High levels of factor IX increase the risk of venous thrombosis. Blood 2000; 95: 3678-82.